Reporter Nov 17 2017

Drug’s effectiveness for neurosarcoidosis studied

A drug commonly prescribed for Crohn’s disease and rheumatoid arthritis is also effective for treating neurosarcoidosis, according to new research led by Vanderbilt neurologists.

Jeff Balser

Rounds: A message from the President and CEO of VUMC

Over the year, Congress has repeatedly attempted to “fix” healthcare by altering the funding streams between states and the federal government, as well as to commercial insurers. All of this might lead one to think that Congress is focused on the most important problems facing healthcare.

Alternatives to emergency room visits abound

More than 50 percent of emergency department visits are unnecessary or avoidable, meaning care could have been provided by a primary care physician or urgent care facility, according to a study from Aetna.

Insurance commissioner outlines ACA challenges

Since 2014 the Affordable Care Act, also known as Obamacare, has assisted lower- and moderate-income people who buy insurance on their own on the individual market, providing premium subsidies and discounts on out-of-pocket expenses. Under the law, people who don’t carry compliant insurance face a penalty, the so-called individual mandate. Large employers who don’t offer insurance are also penalized.

autism concept: puzzle

Study may point to new treatment approach for ASD

Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD).

NFID honors Edwards’ infectious diseases research

Kathryn Edwards, MD, professor of Pediatrics and the Sarah H. Sell and Cornelius Vanderbilt Professor at Vanderbilt University School of Medicine, is the recipient of the 2018 Maxwell Finland Award for Scientific Achievement from the National Foundation for Infectious Diseases (NFID).

1 2